- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Medicure Inc (MPH)
Medicure Inc stock price live, this page displays TSXV MPH stock exchange data. View the MPH premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Medicure Inc real time stock price chart below.
What Is the Medicure Inc Stock Price Today?
The Medicure Inc stock price today is 1.0500.
What Is the Stock Symbol for Medicure Inc?
The stock symbol for Medicure Inc is "MPH."
What Stock Exchange Does Medicure Inc Trade On?
Medicure Inc is listed and trades on the TSXV stock exchange.
Is Medicure Inc a Good Stock to Buy?
Determining whether Medicure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MPH quote. (ISIN: CA58469E4085)
What Is the Medicure Inc Stock Price Today?
The Medicure Inc stock price today is 1.0500.
What Is the Stock Symbol for Medicure Inc?
The stock symbol for Medicure Inc is "MPH."
What Stock Exchange Does Medicure Inc Trade On?
Medicure Inc is listed and trades on the TSXV stock exchange.
Is Medicure Inc a Good Stock to Buy?
Determining whether Medicure Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the MPH quote. (ISIN: CA58469E4085)
1.0500
+0.1000(+10.53%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.0500
1.0500
52 wk Range
0.8500
1.4300
MPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
1.05001.0500
52 wk Range
0.85001.4300
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
MPH Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Medicure Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue surged 44% YoY to CAD 8.5M; full-year revenue rose 32% to CAD 28.9M, driven by pharmacy segment growth (67% of total revenue).
- Net loss widened 610% to CAD 7.1M from CAD 1.0M prior year; stock plunged 33% to $0.45, near 52-week low, on profitability concerns.
- Cash position declined to CAD 3.8M from CAD 7.2M; company maintains zero debt but faces CMS rebate liability and increased AGGRASTAT competition.
- Management focuses on pharmacy expansion and MC-1 phase III trial; recent acquisitions aim to enhance direct-to-patient distribution capabilities.
- Executives cite commitment to operational synergies and addressing unmet medical needs, while navigating regulatory hurdles and macroeconomic pressures.
Last Updated: 2026-04-27, 09:04 a/m
Read Full TranscriptEarnings
Latest Release
Apr 22, 2026
EPS / Forecast
-- / --
Revenue / Forecast
8.54M / --
Compare MPH to Peers and Sector
Metrics to compare | MPH | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMPHPeersSector | |
|---|---|---|---|---|
P/E Ratio | −1.4x | −3.0x | −0.5x | |
PEG Ratio | 0.00 | 0.02 | 0.00 | |
Price/Book | 0.8x | 1.8x | 2.6x | |
Price / LTM Sales | 0.3x | 2.4x | 3.2x | |
Upside (Analyst Target) | - | 92.3% | 50.8% | |
Fair Value Upside | Unlock | −1.8% | 7.7% | Unlock |
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies in the United States. The company markets AGGRASTAT injection, a glycoprotein GP IIb/IIIa receptor antagonist for the treatment of acute coronary syndrome, including unstable angina and non-Q-wave myocardial infarction. It also offers ZYPITAMAG to treat patients with primary hyperlipidemia or mixed dyslipidemia. In addition, the company is developing MC-1 for the treatment of PNPO deficiency; and TARDOXAL for neurological indications, such as Tardive Dyskinesia. It offers products through retail and mail order pharmacies. The company was founded in 1997 and is headquartered in Winnipeg, Canada.
FAQ
What Is the Medicure (MPH) Stock Price Today?
The Medicure stock price today is 1.0500 CAD.
What Stock Exchange Does Medicure Trade On?
Medicure is listed and trades on the TSX Venture Exchange.
What Is the Stock Symbol for Medicure?
The stock symbol for Medicure is "MPH."
What Is the Medicure Market Cap?
As of today, Medicure market cap is 10.9600M CAD.
What Is Medicure's Earnings Per Share (TTM)?
The Medicure EPS (TTM) is 0.6800.
When Is the Next Medicure Earnings Date?
Medicure will release its next earnings report on Jun 02, 2026.
From a Technical Analysis Perspective, Is MPH a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Medicure Stock Split?
Medicure has split 1 times.
How Many Employees Does Medicure Have?
Medicure has 38 employees.
What is the current trading status of Medicure (MPH)?
As of Apr 30, 2026, Medicure (MPH) is trading at a price of 1.0500 CAD, with a previous close of 0.9500 CAD. The stock has fluctuated within a day range of 1.0500 CAD to 1.0500 CAD, while its 52-week range spans from 0.8500 CAD to 1.4300 CAD.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.